Athena Diagnostics,

Athena Diagnostics is a clinical diagnostics service testing laboratory focused on neurology, endocrinology and nephrology. As a leader in genetic testing and personalized medicine, Athena's mission is to improve the lives of patients by providing the best possible diagnostic services to their physicians. Started as Genica Pharmaceuticals in 1988, Athena Diagnostics has undergone several changes of control: acquired by Athena Neuroscience in 1995, acquired by Elan Pharmaceuticals in 1996, acquired by Behrman Capital in 2002, acquired in 2006 by Fisher Scientific, which became Thermo Fisher, and acquired by Quest Diagnostics in 2011. Athena has over 300 diagnostic tests, 300 employees and 2010 revenues of $110 million.